Results 271 to 280 of about 1,917,601 (292)

Role of Eosinophil Mitochondrial Function in Severe Eosinophilic Asthma

A101. LINKING BIOLOGY TO THE REAL WORLD IN ASTHMA AND ALLERGIC INFLAMMATION, 2023
J.B. Koranteng, S.L. Lai, K.L. Raby, P. Dixey, K.F. Chung, C. Michaeloudes, P.K. Bhavsar   +6 more
openaire   +1 more source

Real-World Multicenter Experience With Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months

Journal of Asthma and Allergy, 2021
Nikolaus Kneidinger, Nora Drick, Hendrik Suhling   +2 more
exaly  

Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma. A Systematic Review for the EAACI Guidelines - Recommendations on the Use of Biologicals in Severe Asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Jonathan Corren, Yang Song, Ioana Agache
exaly  

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy

International Journal of Molecular Sciences, 2021
Agamemnon Bakakos, Petros Bakakos, Nikoletta Rovina   +2 more
exaly  

Lysis of primed eosinophils in severe asthma

Journal of Allergy and Clinical Immunology, 2013
openaire   +2 more sources

BIOLOGICS SWITCH IN SEVERE EOSINOPHILIC ASTHMA

Airway pharmacology and treatment, 2021
Caminati, Marco, Guarnieri, Gabriella, Bagnasco, Diego, Chieco Bianchi, Fulvia, Carpagnano, Elisiana, Maule, Matteo, Molena, Beatrice, Pelaia, Girolamo, Pini, Laura, Senna, Gianenrico, Vianello, Andrea, Crisafulli, Ernesto   +11 more
openaire   +1 more source

Benralizumab (Fasenra) for Severe Eosinophilic Asthma

JAMA, 2018
openaire   +2 more sources

Mepolizumab for Severe Eosinophilic Asthma (DREAM): A Multicentre, Double-Blind, Placebo-Controlled Trial

Lancet, The, 2012
Hector Ortega, Ian D. Pavord, Eugene R Bleecker   +2 more
exaly  

Treatment for Severe Eosinophilic Asthma—Consistent Effect of Anti-Interleukin-5 Antibodies?

Lancet, The, 2016
Mario Castro, Leonard Bacharier
exaly  

Long-Term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Clinical Therapeutics, 2019
Robert G Price, Guy Brusselle, Frank Albers   +2 more
exaly